Drugs that contain Ziconotide Acetate

1. List of Prialt drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8653033 TERSERA Method for administering omega-conopeptide
Oct, 2024

(1 year, 8 months from now)

US8765680 TERSERA Method for administering omega-conopeptide
Oct, 2024

(1 year, 8 months from now)

US9707270 TERSERA Method for administering ω-conopeptide
Oct, 2024

(1 year, 8 months from now)

Market Authorisation Date: 28 December, 2004

Treatment: Analgesia; Treatment of pain; Treatment of severe chronic pain via intrathecal infusion of ziconotide in patients also receiving morphine

Dosage: INJECTABLE;INTRATHECAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic